KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED Revenue and Competitors
Estimated Revenue & Valuation
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's estimated annual revenue is currently $14.8M per year.
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's estimated revenue per employee is $220,500
Employee Data
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED has 67 Employees.
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED grew their employee count by 22% last year.
KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's People
Name | Title | Email/Phone |
---|
KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.6M | 84 | 1% | $10M | N/A |
#2 | $34.1M | 139 | 46% | N/A | N/A |
#3 | $179.2M | 576 | -3% | $49.4M | N/A |
#4 | $326.5M | 952 | 11% | N/A | N/A |
#5 | $8.4M | 43 | -12% | N/A | N/A |
#6 | $9.4M | 48 | 4% | N/A | N/A |
#7 | $7.3M | 37 | -5% | $3M | N/A |
#8 | $48.2M | 179 | -3% | N/A | N/A |
#9 | $121M | 395 | 13% | N/A | N/A |
#10 | $372.8M | 1087 | 10% | N/A | N/A |
What Is KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED?
Klenzaids delivers Regulatory Compliant Turnkey "Design-Buildâ??Projects within:\n\nA | Aseptic\nB | BioClean\nC | Containment\n\nThese include Cleanrooms; Biological-Chemical Containment Facilities and Laboratories; Microenvirons and Laboratories for Active Ingredients and Formulations in the Pharmaceutical, Life-Science, BioTechnology, Electronics, Aerospace, Food, Healthcare and Cosmetic sectors. \n\nKlenzaids known for its strong IPR and patents, manufactured specialized benchmark equipments and devices, for clients across the globe.
keywords:N/AN/A
Total Funding
67
Number of Employees
$14.8M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.4M | 67 | 6% | N/A |
#2 | $6.2M | 67 | 24% | N/A |
#3 | $13.9M | 68 | 26% | N/A |
#4 | $8.9M | 68 | 8% | N/A |
#5 | $12.9M | 68 | -15% | N/A |